Igor Uppal

DNP Doctor of Nursing Practice,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Sales and Marketing Pharma-CRO-Device IT-Web-Mobile Technology Scientific Writing

Areas Of Interest

Spastic Paraplegia Type 2 Ro 10-1670 Russell's Viper Venom Time Genes, HER-2 Ehlers Danlos Syndrome, Sack-Barabas Type Ganglioglioma Epidermal Growth Factor-Related Transforming Growth Factor Human Papillomavirus Virus Encephalopathies, Post-Concussive Screen, X-Ray Intensifying Adoptive Cell Transfer Tool Use Behaviors t Butylhydroperoxide Chives Region, Immunoglobulin Hypervariable GAT-2 Transporter Pfiesteria piscicida Plasma Cell Myelomas Rest, Bed Acids, Arylsulfonic Collagens, Short-Chain Flanking Region, 5' Potassium Channels, Calcium Dependent Internet Based Intervention Vomica, Nux Click Chemical Techniques Macroglossia Nutrition Value Colicines Crash Team, Cardiac Retinal Cone Photoreceptor Cells Immunomagnetic Separation Derivatives, Lupane Armadillo Motif Proteins Passive Smokings Pericarditis, Constrictive Hemlocks, Poison Chronic Granulocytic Leukemia

Professional Narrative

Dr. Igor Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Mayo Clinic 2001
Assistant Professor, Harvard Med 1991

Education

Master of Science in physician assistant, Weill Medical College 2015
Doctor of osteopathic medicine, Perelman School of Medicine 2013

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02